Evidence map›Paper›PMID 25172499›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2014

Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults.

Ramin Sedaghat Herati, Morgan A Reuter, Douglas V Dolfi, Kathleen D Mansfield, Htin Aung, Osama Z Badwan, Raj K Kurupati, Senthil Kannan, Hildegund Ertl, Kenneth E Schmader and 3 more

2 registry-linked trialsOpen access · greenAbstract readClinical TrialComparative StudyMulticenter Study
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04499534 active not recruitingnot on this mapstarted 2019, after this paper: background citation

Influenza Vaccine Study in BRCA1 or BRCA2 Carriers

TypeobservationalSponsorAbramson Cancer Center at Penn MedicineRan2019 to 2027Enrolled50ConditionsBRCA1 Mutation, BRCA2 MutationArmsSeasonal influenza vaccine
NCT04568044 unknown statusnot on this mapstarted 2020, after this paper: background citation

Evaluation of Cell-mediated and Humoral Immunity Following COVID-19 in Pregnancy

TypeobservationalSponsorImperial College LondonRan2020 to 2025Enrolled128ConditionsCOVID-19, Pregnancy Related, Influenza, HumanArmsBlood sample
3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 177 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Upregulation of CCR4 in activated CD8European journal of immunology · 2021
    Trial
  4. Protein/AS01Cell reports. Medicine · 2021
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  11. Article
  12. Article
  13. Antiviral CD4Communications medicine · 2026
    Article
  14. Influenza vaccine-specific CD4NPJ vaccines · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Ramin Sedaghat HeratiDepartment of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104;
Morgan A ReuterInstitute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104;
Douglas V DolfiInstitute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; Janssen Research & Development, Spring House, PA 19477;
Kathleen D MansfieldInstitute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; Janssen Research & Development, Spring House, PA 19477;
Htin AungDivision of Infectious Disease, Case Western Reserve University, Cleveland, OH 44106; Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 44106;
Osama Z BadwanDivision of Infectious Disease, Case Western Reserve University, Cleveland, OH 44106; Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 44106;
Raj K KurupatiWistar Institute, Philadelphia, PA 19104;
Senthil KannanWistar Institute, Philadelphia, PA 19104;
Hildegund ErtlWistar Institute, Philadelphia, PA 19104;
Kenneth E SchmaderDivision of Geriatrics, Department of Medicine, Duke University Medical Center, Durham, NC 27710; and Geriatric Research, Education, and Clinical Center, Durham VA Medical Center, Durham, NC 27705.
Michael R BettsInstitute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104;
David H CanadayDivision of Infectious Disease, Case Western Reserve University, Cleveland, OH 44106; Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH 44106;
E John WherryInstitute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; wherry@mail.med.upenn.edu.
University of Pennsylvania · USThe Wistar Institute · USGeriatric Research Education and Clinical Center · USCase Western Reserve University · USDurham VA Medical Center · USJanssen (United States) · USSpringhouse · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Alan David Levine · 1994 to 2026
$50.0M
Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Sarah B. Peskoe · 2006 to 2026
$24.6M
TRAINING IN HIV PATHOGENESIST32AI007632 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Frederic D Bushman, James L. Riley · 2000 to 2026
$10.6M
T cell functionality and control of HIV infectionR01AI076066 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BETTS, MICHAEL R · 2008 to 2017
$4.6M
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older aduR01AI108972 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BETTS, MICHAEL R, CANADAY, DAVID H · 2014 to 2018
$2.5M
Mechanisms of increased susceptibility to TB in HIV-Infected individualsR01AI080313 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI CANADAY, DAVID H · 2010 to 2013
$2.0M
NIAID NIH HHS 5T32 AI007632NIAID NIH HHS AI080313NIAID NIH HHS AI36219NIAID NIH HHS HHSN266200500030CNIAID NIH HHS P30 AI036219NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI076066NIAID NIH HHS R01 AI080313NIAID NIH HHS R01 AI108972NIAID NIH HHS T32 AI007632NIA NIH HHS AG028716NIA NIH HHS P30 AG028716
6 · The paper itself

Abstract

Although influenza vaccination is recommended for all adults annually, the incidence of vaccine failure, defined as weak or absent increase in neutralizing Ab titers, is increased in the elderly compared with young adults. The T follicular helper cell (Tfh) subset of CD4 T cells provides B cell help in germinal centers and is necessary for class-switched Ab responses. Previous studies suggested a role for circulating Tfh cells (cTfh) following influenza vaccination in adults, but cTfh have not been studied in elderly adults in whom weak vaccine responses are often observed. In this study, we studied cTfh expressing CXCR5 and programmed death-1 (PD-1). cTfh from elderly adults were present at reduced frequency, had decreased in vitro B cell help ability, and had greater expression of ICOS compared with young adults. At 7 d after inactivated influenza vaccination, cTfh correlated with influenza vaccine-specific IgM and IgG responses in young adults but not in elderly adults. In sum, we have identified aging-related changes in cTfh that correlated with reduced influenza vaccine responses. Future rational vaccine design efforts should incorporate Tfh measurement as an immune correlate of protection, particularly in the setting of aging.

Indexed as

Programmed Cell Death 1 ReceptorReceptors, CXCR5AdultAge FactorsAgingAntibodies, ViralAntibody FormationB-LymphocytesCD4-Positive T-LymphocytesFemaleGerminal CenterHumansImmunoglobulin GImmunoglobulin MInfluenza VaccinesMaleAntibodies, ViralCXCR5 protein, humanImmunoglobulin GImmunoglobulin MInfluenza VaccinesPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, CXCR5

Identifiers

PMID25172499
PMCPMC4170011
OpenAlexW1957514873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.